blog

NIH Announces Funding for Novel Contraceptive Methods
The National Institutes of Health has released a new funding solicitation to support the development of novel nonsteroidal contraceptive methods. Read full article
blog

Contraceptive Technology Innovation: A Wise Investment
As long as women and men find current family planning methods unacceptable, unaffordable, or inaccessible, there will be a need to invest in contraceptive technology innovation. Read full article
blog

Contraceptive Technology Innovation: It’s Everyone’s Business
Everyone must be engaged to move the science of contraceptive technology innovation forward – to bring it out of the laboratories and get it to the people who need it on the ground. Read full article
event

Upcoming Webinar: “Imagining the future of women’s contraception”
This month, the Reproductive Health Supplies Coalition will twice host the webinar: “Imagining the future of women’s contraception: Results from the CT Innovation Lab Workshops in Kenya ... View Event
blog

Ferring Pharmaceuticals to Issue Biomarker Research Grants
Applications for Ferring Pharmaceuticals’ Innovation Grants Program to support biomarker research are due June 11.  Read full article
blog

Getting Behind Human-Centered Design for Contraceptive Innovation
With high unmet need for family planning methods still present, a huge opportunity exists to look at new ways to design products that respond to women’s needs and preferences, rather than ... Read full article
blog

Vaginal Rings: The Future is Now
Successes and lessons learned from Progering and Dapivrine —the first vaginal rings to be introduced—will be critical in informing the introduction of the rings currently in development. Read full article
blog

Blocking Sperm by Reinforcing Cervical Mucus
How novel would it be if one of women’s own natural barriers – cervical mucus – could be the basis for a highly effective, game-changing contraceptive. Read full article
blog

Sperm Motility Inhibited in Study of Male Macaques
Newly published research suggests that EP055 could become the basis for an effective, reversible, short-acting, non-hormonal male contraceptive. Read full article
blog

Building the Foundation for Developing Next-Gen Contraceptives
Discovery of new contraceptive agents will remain elusive unless something changes to dramatically improve the state-of-the-art for contraceptive screening and pre-clinical testing, making t... Read full article
blog

A Chicken or Egg Dilemma: Reducing Commodity Costs When Scaling up Contraceptive Implants
In the past decade, use of contraceptive implants in sub-Saharan Africa has increased dramatically, in large part due to major reductions in price.  Read full article
event

IMPT Seminar to Focus on Longer-Acting Technologies
“Opportunities and Challenges for Long-Acting MPTs,” the second in a series of technical webinars focused on multi-purpose technologies, will be held on May 2. View Event